Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old
- Your lung function test results (a breathing test called FEV1) meet acceptable levels as defined by international standards
- You are willing and able to follow the study procedures
- A doctor has diagnosed you with asthma at least 3 months before your screening appointment
Who may not be able to join:
- You have had problems with alcohol or drug misuse in the past year
- You are pregnant at the time of any study assessment
- You have confusion or difficulty understanding information at the time of signing the consent form
- You have received certain biological medicines (whether standard treatments or experimental ones) within the past 3 months or within a specific washout period before your first visit, whichever is longer (confirm with trial site)
- You have had a respiratory infection (such as a cold, chest infection, or similar illness) or related symptoms within 2 weeks before your baseline assessments
- You have a serious terminal illness, organ failure, or another condition that the study team considers makes participation unsuitable
- You have taken certain asthma medicines called LTRAs or 5-lipoxygenase inhibitors (for example, montelukast or zileuton) within 1 month or a specific washout period before your baseline visit, whichever is longer (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Descriptive summary of demographic and subject characteristic, clinical characteristics and functional deliverables.; Descriptive summary of biomarker level.; Statistical clustering of key biomarkers.; FEV1 level; Forced Vital Capacity (FVC); Maximal Mid Expiratory Flow (MMEF); Airway remodeling; Gas trapping; Computed Tomography (CT) Scan
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.